Blog Stats
- 84,265 hits
www.friedmanconsultingllc.com
Blogroll
Franck's Pharmacy
InfuPharma
IPA Canada Seminars
New England Compounding Center
TUNGSTEN SHIELD WEBINARS
Warning Letters
-
Recent Posts
- FDA CDER Most Frequent Form FDA 483 Observations Fiscal Year 2012
- APOTEX INC RECEIVES WARNING LETTER FOR MULTIPLE CANADIAN SITES (2/21/13) PART II
- APOTEX INC RECEIVES WARNING LETTER FOR MULTIPLE CANADIAN SITES (2/21/13)
- JUBILANT HOLLISTERSTIER RECEIVES WARNING LETTER (2/13/13)
- MEDI-FARE DRUG AND HOME HEALTH CENTER, BLACKSBURG, SC RECEIVES WARNING LETTER (3/7/13)
Archives
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
Categories
- 483
- Adverse Determination Letter
- Compounding Pharmacy
- Consent Decree
- Dietary Supplements
- FDA Compliance
- Import Alert
- Import Ban
- Microbiological Issues
- New Guidances for Industry
- Permanent Injunction
- Positron Emission Tomography (PET)
- Purpose and Scope
- Recall
- Regulatory Compliance
- Seizure
- Uncategorized
- Warning Letters
- Webinar
Pages
- 2013 UPCOMING WEBINAR/CONFERENCES/SEMINARS (UPDATED 02/28/13)
- ABOUT
- “HOT TOPICS” AVAILABLE FOR USP GENERAL CHAPTER PET 823
- Guidance – PET Drugs – cGMP (August 2011)
- MEDIA FILLS FOR VALIDATION OF ASEPTIC PREPARATIONS FOR POSITRON EMISSION TOMOGRAPHY(PET)
- Proposed Changes to USP General Chapter 823 March 30, 2011
- REGULATORY COMPLIANCE/EXPERT MICROBIOLOGICAL WITNESS CONSULTATION
- USP 61/62 FREQUENTLY ASKED QUESTIONS
Tags
Accugenix API Aseptic Processing Bacillus cereus bacterial contamination Ben Venue CDER CMO Consent Decree DNA Sequencing Environmental Monitoring FDA FDA 483 FDA Compliance FDA Guidance for Industry Growth Promotion H & P Industries Hospira interventions Johnson & Johnson McNeil-PPC media fills microbial contamination NECC Objectionable microorganisms Observations OOS PDI Permanent Injunction PET Puerto Rico purified water Ranbaxy Recall seizure sterile drug products Sterility Sterility Test training Triad Group USP USP 62 Validation Warning Letter Warning LettersMeta
Tag Archives: Triad Group
VAGINA COSMETICS RECALLED FOR CONTAINING MICROORGANISMS AND BENZOCAINE
EFFECT OF MICROBIAL CONTAMINATION DIFFICULT TO ASSESS COMMENT USA Far Ocean Group issued a voluntary recall following FDA’s laboratory analyses of “Vagifresh Gel” and “Vagifresh Ball”. The former contained benzocaine, while the later contained bacteria from a number of species to … Continue reading
PROFESSIONAL DISPOSABLES INTERNATIONAL, INC, ORANGEBURG, NY RECEIVES FORM FDA 483 (7/5/11)
BACILLUS CEREUS RECOVERED FROM APPLICATOR USED TO MANUFACTURE NON-STERILE ALCOHOL PREP PADS OBSERVATION 1 Each lot of a component that is liable for microbiological contamination that is objectionable in view of its intended use is not subjected to microbiological tests … Continue reading
SECOND WIPE-MAKER ISSUES RECALL AFTER BACTERIA DETECTED
NON-STERILE WIPES RECALLED ON SEPTEMBER 16, 2011 FOLLOWING DISCOVERY OF LOW LEVELS OF BACILLUS CEREUS COMMENT Bacillus cereus was recently identified within non-sterile alcohol prep wipes manufactured by Professional Disposables International Inc (PDI), Orangeburg, NY. The recall of five lots … Continue reading
H and P Industries Lawsuit Ties Tainted Wipes to Twin’s Brain Damage
MSNBC Reports On On-Going Rare Bacterial Infection Stumped Experts Until News Of Contaminated Products Surfaced For nearly four years, a bacterial infection that left a Seattle-area newborn with severe brain damage while his twin brother developed normally has remained a … Continue reading
Posted in FDA Compliance, Regulatory Compliance
Tagged alcohol prep pads, Bacillus cereus, Cardinal Health, Daniel Benjamin MD, Evergreen Hospital, H & P Industries, Joel Cunningham, Major Pharmaceuticals, Mary McIntyre, Myles Massey, sterile lubricating jelly, Triad Group, Tudor Converted Products
1 Comment
TRIAD GROUP AND H & P INDUSTRIES RECEIVE ANOTHER FDA-483 ON MARCH 28, 2011
FDA-483 ARRIVES ONE WEEK PRIOR TO SEIZURE Comment The FDA released additional information regarding its most recent inspection (March 21 – 28, 2011) in the same press release that described its seizure of over $6 million dollars of various drug … Continue reading
Posted in 483, FDA Compliance, Recall, Seizure
Tagged FDA 483, FDA Compliance, providone-iodine, Triad Group
1 Comment
FDA ORDERS SEIZURE OF TRIAD PRODUCT WORTH $6 MILLION
FDA Orders Seizure Of Antiseptic, Antifungal Products Worth $6 Million The AP (4/6) reported that the Food and Drug Administration “said Wednesday that antiseptic products made by Triad Group and H&P Industries were seized to prevent the distribution of products … Continue reading
TRIAD GROUP RAIDED BY U.S. MARSHAL SERVICE (APRIL 4, 2011)
TRIAD GROUP RAIDED BY U.S. MARSHAL SERVICE (APRIL 4, 2011) See also new FDA-483 from March 28, 2011 (Link attached below) HARTLAND, Wis.— A medical products maker in Hartland ceased production Monday after the U.S. Marshals Service arrived to quarantine or seize … Continue reading
Posted in 483, FDA Compliance, Recall
Tagged Bacillus cereus, FDA 483, quarantine, seizure, Triad Group, Triad Group Raided, U.S. Marshall Service
Leave a comment
TRIAD GROUP HARTLAND, WI FORM FDA-483 INSPECTION DATES 11/29/2010 – 1/7/11
Triad Group Hartland, WI Form FDA-483 Inspection Dates 11/29/2010 – 1/7/2011 Comment Enclosed are comments from a total of seven observations representing various Systems to include Laboratory Control, Production, and Material obtained as a subset from the forty six observations … Continue reading
Posted in 483, FDA Compliance
Tagged alcohol pads, component supplier, FDA 483, microbial bioburden, pyrogen-free, Sterile, Triad Group, USP, USP 61, USP 71
Leave a comment
TRIAD GROUP — VOLUNTARY PRODUCT RECALL AND FDA 483
TRIAD GROUP – VOLUNTARY PRODUCT RECALL JANUARY 5, 2011 FOR IMMEDIATE RELEASE – January 5, 2011 – Hartland, Wisconsin, Triad Group, a manufacturer of over-the-counter products has initiated a voluntary product recall involving ALL LOTS of ALCOHOL PREP PADS, ALCOHOL SWABS, … Continue reading
Posted in 483, FDA Compliance, Recall
Tagged Bacillus cereus, FDA 483, Recall, spore forming microorganism, Triad Group
Leave a comment
